Actinomycin D downregulates Sox2 and improves survival in preclinical models of recurrent glioblastoma
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Actinomycin D downregulates Sox2 and improves survival in preclinical models of recurrent glioblastoma
Authors
Keywords
-
Journal
NEURO-ONCOLOGY
Volume -, Issue -, Pages -
Publisher
Oxford University Press (OUP)
Online
2020-03-06
DOI
10.1093/neuonc/noaa051
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Targeting of replicating CD133 and OCT4/SOX2 expressing glioma stem cells selects a cell population that reinitiates tumors upon release of therapeutic pressure
- (2019) Marta Guerra-Rebollo et al. Scientific Reports
- Procarbazine and CCNU Chemotherapy for Recurrent Glioblastoma with MGMT Promoter Methylation
- (2018) Se-Hyuk Kim et al. JOURNAL OF KOREAN MEDICAL SCIENCE
- DNA methylation-based classification of central nervous system tumours
- (2018) David Capper et al. NATURE
- High content screening of patient-derived cell lines highlights the potential of non-standard chemotherapeutic agents for the treatment of glioblastoma
- (2018) Kenny Kwok-Hei Yu et al. PLoS One
- Concordant association validates MGMT methylation and protein expression as favorable prognostic factors in glioma patients on alkylating chemotherapy (Temozolomide)
- (2018) Arshad A. Pandith et al. Scientific Reports
- Bevacizumab and re-irradiation for recurrent high grade gliomas: does sequence matter?
- (2018) Joshua D. Palmer et al. JOURNAL OF NEURO-ONCOLOGY
- Human glioblastoma arises from subventricular zone cells with low-level driver mutations
- (2018) Joo Ho Lee et al. NATURE
- Development of a physiologically based pharmacokinetic model of actinomycin D in children with cancer
- (2016) Christopher Walsh et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Inhibition of SOX2 induces cell apoptosis and G1/S arrest in Ewing’s sarcoma through the PI3K/Akt pathway
- (2016) Chongmin Ren et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- A phase II trial evaluating the effects and intra-tumoral penetration of bortezomib in patients with recurrent malignant gliomas
- (2016) Jeffrey J. Raizer et al. JOURNAL OF NEURO-ONCOLOGY
- Effect of low doses of actinomycin D on neuroblastoma cell lines
- (2016) Constanza L. Cortes et al. Molecular Cancer
- Low-dose Actinomycin-D treatment re-establishes the tumoursuppressive function of P53 in RELA-positive ependymoma
- (2016) Theophilos Tzaridis et al. Oncotarget
- Phenotypic Plasticity Determines Cancer Stem Cell Therapeutic Resistance in Oral Squamous Cell Carcinoma
- (2016) Adrian Biddle et al. EBioMedicine
- Nestin as a marker of cancer stem cells
- (2015) Jakub Neradil et al. CANCER SCIENCE
- Mir-21-Sox2 Axis Delineates Glioblastoma Subtypes with Prognostic Impact
- (2015) P. Sathyan et al. JOURNAL OF NEUROSCIENCE
- Strategies to improve delivery of anticancer drugs across the blood–brain barrier to treat glioblastoma
- (2015) Rajneet K. Oberoi et al. NEURO-ONCOLOGY
- Conversion of differentiated cancer cells into cancer stem-like cells in a glioblastoma model after primary chemotherapy
- (2014) B Auffinger et al. CELL DEATH AND DIFFERENTIATION
- Treatment Considerations for MGMT-Unmethylated Glioblastoma
- (2014) Jennie W. Taylor et al. Current Neurology and Neuroscience Reports
- Changing incidence and improved survival of gliomas
- (2014) Vincent K.Y. Ho et al. EUROPEAN JOURNAL OF CANCER
- Analysis of an artificial zinc finger epigenetic modulator: widespread binding but limited regulation
- (2014) Matthew R. Grimmer et al. NUCLEIC ACIDS RESEARCH
- The multiple roles for Sox2 in stem cell maintenance and tumorigenesis
- (2013) Kuancan Liu et al. CELLULAR SIGNALLING
- Myeloid/Microglial Driven Autologous Hematopoietic Stem Cell Gene Therapy Corrects a Neuronopathic Lysosomal Disease
- (2013) Ana Sergijenko et al. MOLECULAR THERAPY
- Mutational Analysis Reveals the Origin and Therapy-Driven Evolution of Recurrent Glioma
- (2013) B. E. Johnson et al. SCIENCE
- 5S Ribosomal RNA Is an Essential Component of a Nascent Ribosomal Precursor Complex that Regulates the Hdm2-p53 Checkpoint
- (2013) Giulio Donati et al. Cell Reports
- SOX2 Gene Regulates the Transcriptional Network of Oncogenes and Affects Tumorigenesis of Human Lung Cancer Cells
- (2012) Si Chen et al. PLoS One
- Inhibition of cancer stem cell-like properties and reduced chemoradioresistance of glioblastoma using microRNA145 with cationic polyurethane-short branch PEI
- (2011) Yi-Ping Yang et al. BIOMATERIALS
- ID4 Imparts Chemoresistance and Cancer Stemness to Glioma Cells by Derepressing miR-9*-Mediated Suppression of SOX2
- (2011) H.-M. Jeon et al. CANCER RESEARCH
- Identification of a SOX2-dependent subset of tumor- and sphere-forming glioblastoma cells with a distinct tyrosine kinase inhibitor sensitivity profile
- (2011) Daniel Hägerstrand et al. NEURO-ONCOLOGY
- A Versatile Viral System for Expression and Depletion of Proteins in Mammalian Cells
- (2009) Eric Campeau et al. PLoS One
- Comprehensive genomic characterization defines human glioblastoma genes and core pathways
- (2008) Roger McLendon et al. NATURE
- An embryonic stem cell–like gene expression signature in poorly differentiated aggressive human tumors
- (2008) Ittai Ben-Porath et al. NATURE GENETICS
- SOX2Silencing in Glioblastoma Tumor-Initiating Cells Causes Stop of Proliferation and Loss of Tumorigenicity
- (2008) Rosaria Maria Rita Gangemi et al. STEM CELLS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More